In models of retinal degeneration, Epitalon has been delivered via parabulbar injection, a technique that places the compound near the posterior eye to maximize local availability [64, 65]
Chronic pain can have multiple drivers, including nerve irritation, metabolic inflammation, and biomechanical compensation
Several human studies appear to have been cancelled or stopped without published results a gap that cannot be glossed over clinically [1]
These trials are of low quality, and as such, use in widespread clinical practice is premature
No, the fillers we use these days arent permanent, and thats a good thing because its unlikely that filler placed today would look natural in 10 years if it stayed exactly the same, because so much changes about our faces as we age